|
|
Analysis of 178 serious adverse drug reactions |
LI Xiang XU Ping |
Department of Pharmacy, Heyuan People′s Hospital, Guangdong Province, Heyuan 517000, China |
|
|
Abstract Objective To analyze the characteristics and rules of serious adverse drug reactions (ADR) in Heyuan People′s Hospital, to provide references for clinical rational use of drugs. Methods A total of 178 patients with severe ADR who were reported to Guangdong ADR Monitoring System by Heyuan People′s Hospital from January 2018 to December 2019 were selected as the research subjects for retrospective analysis, including the general conditions of severe ADR patients, combined medication, the route of administration, the types of drugs, and the organs/system and other content. Results Of 178 serious ADR cases, the male to female ratio was 1∶0.91, with slightly more males than females.The number of patients aged >60 years was the largest, accounting for 42.70%. The number of severe ADR cases caused by one drug combination was the largest, accounting for 87.09%. Intravenous infusion was the most important way to cause severe ADR, accounting for 83.71%. The number of severe ADR cases caused by anti-infective drugs was the largest, accounting for 27.53%, followed by traditional Chinese medicine injections, accounting for 11.80%. Among the anti-infective drugs causing severe ADR, quinolones were the most, accounting for 28.57%. The most severe ADR involved organs/systems was skin and its appendages. New severe ADR and severe ADR accounted for 37.08% and 62.92%, respectively. After corresponding treatment, 147 cases of severe ADR were improved, 28 cases were cured, 2 cases were unknown, and 1 case was not improved. Conclusion It is necessary to strengthen the supervision of anti-infective drugs and traditional Chinese medicine injections, and standardize their use; and strengthen the monitoring of serious ADR, reduce or avoid the occurrence of serious ADR, and promote rational clinical use of drugs.
|
|
|
|
|
[1] |
陈新谦,金有豫,汤光.新编药物学[M].17 版.北京:人民卫生出版社,2011.
|
[2] |
苏进,易文燕,王世玉.我院456 例严重药品不良反应回顾性分析[J].中国当代医药,2020,27(10):182-184,188.
|
[3] |
陈思颖,尤海生,朱亚宁,等.134 例严重药品不良反应/事件报告分析[J].药物流行病学杂志,2016,25(9):559-562.
|
[4] |
游翠玉,许晓丽,李莎,等.某院140 例严重药品不良反应/事件报告分析[J].中国药物警戒,2020,17(9):617-621,648.
|
[5] |
吴仪,郑筱萸.药品不良反应报告和监测管理办法[J].中国药事,2004,23(4):203-205.
|
[6] |
游利江,李荣.严重药品不良反应125 例分析[J].临床合理用药杂志,2019,12(13):7-8,10.
|
[7] |
胡骅,项玮,叶明全.某市抗生素类药物不良反应报告综合分析[J].中国当代医药,2020,27(4):207-212.
|
[8] |
吴小枫,杨嘉永,颜志文,等.我院307 例严重的药品不良反应报告分析[J].海峡药学,2019,31(10):249-253.
|
[9] |
李旭,于军.老年人合理用药分析[J].中国老年学杂志,2019,39(7):1789-1791.
|
[10] |
朱建祥,梁小銮.严重药品不良反应148 例报告分析[J].临床合理用药杂志,2019,12(7):17-19.
|
[11] |
杨会珍.心脑血管疾病药物不良反应的临床分析及其合理应用对策[J].中国现代药物应用,2020,14(10):205-206.
|
[12] |
王秀玲,宋伟,蔡其明.单唾液酸四己糖神经节苷脂钠注射液致新的/严重的不良反应分析[J].解放军药学学报,2017,33(3):282-284.
|
[13] |
周坤.喹诺酮类抗菌药物临床应用的研究近况[J].抗感染药学,2020,17(6):782-785.
|
[14] |
杨澍,崔艳丽,高秀清,等.β-内酰胺酶抑制剂复合制剂的不良反应文献分析[J].现代药物与临床,2016,31(1):106-110.
|
[15] |
易艳,李春英,赵雍,等.中药注射剂不良反应及类过敏反应研究进展[J].中国中药杂志,2021,46(7):1711-1716.
|
[16] |
原海晓,余应嘉,袁杰.广州市中西医结合医院中药注射剂不良反应发生情况与分析[J].中医临床研究,2019,11(32):126-128.
|
[17] |
周鹏,姜晓芹,崔岚.107 例严重药品不良反应/事件报告分析[J].中国药物应用与监测,2016,13(6):356-359.
|
[18] |
王彬,黄淑贞,陈聪华.308 例儿童药品不良反应回顾性分析[J].儿科药学杂志,2021,27(1):49-52.
|
[19] |
王敏.医疗机构药品不良反应监测现状与对策研究[J].药学服务与研究,2016,16(5):359-362.
|
[20] |
周鹏,祝红英,崔岚.某三级甲等医院医务人员药品不良反应上报情况及漏报原因调查分析[J].中国药房,2017,28(36):5056-5059.
|
|
|
|